Evaluation of C-Reactive Protein/Albumin Ratio in Diabetic Retinopathy Patients
Diagnostics · 28.08.2025 · 15 (17) · 2178
DOI: 10.3390/diagnostics15172178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 28.08.2025. Verfasst von Şaban Kılıç und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Samsun Education and Research Hospital, Kısla, Barıs Blv. No:199, 55090 Samsun, Turkey. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
This study aimed to investigate the relationship between the C-reactive protein/albumin (CRP/albumin) ratio and disease severity in diabetic retinopathy (DR) patients and to evaluate the potential of CRP/albumin as a clinical biomarker for inflammation and DR progression.
Methods
This single-center, prospective, cross-sectional study included 158 DR patients and 150 healthy controls. Clinical, ophthalmologic, and laboratory evaluations were performed, including best-corrected visual acuity, optical coherence tomography, and measurements of inflammatory and glycemic markers. CRP/albumin ratios were calculated, and their relationships with DR severity were assessed. Receiver operating characteristic (ROC) analysis was performed to evaluate the predictive performance of CRP/albumin.
Results
Before treatment, CRP/Alb ratios and other inflammatory markers, including NLR, MLR, PLR, and SII, were significantly elevated in DR patients compared to controls. Following treatment, CRP/albumin ratios decreased markedly from 0.14 ± 0.1 to 0.04 ± 0.04 (p < 0.001), aligning with improvements in retinal thickness (OCT: 269.2 ± 17.5 µm) and HbA1c levels (6.9 ± 1.2%). CRP levels decreased from 5.8 ± 3.2 mg/L to 1.5 ± 1.4 mg/L, while NLR dropped from 2.5 ± 1.1 to 1.29 ± 0.8 (p < 0.001). Significant reductions were also observed in PLR (169.6 ± 62.2 to 128.2 ± 54.3) and SII (743.0 ± 427 to 230.8 ± 187). ROC analysis revealed an AUC of 0.963 for CRP/albumin, indicating high predictive accuracy for DR severity with 95% sensitivity and 90% specificity at a cutoff of 0.052.
Conclusions
The CRP/albumin ratio is a significant biomarker for inflammation and disease progression in DR. The observed reductions in inflammatory markers post-treatment highlight the importance of inflammation control in DR management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Samsun Education and Research Hospital, Kısla, Barıs Blv. No:199, 55090 Samsun, Turkey.
ORCID-Profile: Şaban Kılıç, Çiğdem Deniz Genç
Zitieren
APA
Kılıç, Ş., Aydın, E., & Genç, Ç. D. (2025). Evaluation of C-Reactive Protein/Albumin Ratio in Diabetic Retinopathy Patients. Diagnostics, 15(17), 2178. https://doi.org/10.3390/diagnostics15172178
Vancouver
Kılıç Ş, Aydın E, Genç ÇD. Evaluation of C-Reactive Protein/Albumin Ratio in Diabetic Retinopathy Patients. Diagnostics. 2025;15(17):2178. doi:10.3390/diagnostics15172178
BibTeX
@article{Kl2025,
author = {Kılıç, Şaban and Aydın, Emre and Genç, Çiğdem Deniz},
title = {Evaluation of C-Reactive Protein/Albumin Ratio in Diabetic Retinopathy Patients},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {17},
pages = {2178},
doi = {10.3390/diagnostics15172178}
}
EUVIMED